Biogen Idec Partners With Cardiokine On Vasopressin Antagonist For Hyponatremia
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase III trials of the oral drug, which will start this year, are expected to take two years to complete, Biogen says.